165 Results

People

  1. Old
    Old
  2. Ritter
    Ritter
  3. Houghton
    Houghton
  4. Gnjatic
    Gnjatic
  5. Allison
    Allison
  6. Pamer
    Pamer
  7. Fong
    Fong
  8. Dupont
    Dupont
  9. Scheinberg
    Scheinberg
  10. Wolchok
    Wolchok

Groups

  1. Department of Medicine (56)
  2. Sloan Kettering Institute Faculty (56)
  3. GSK Faculty (53)
  4. Immunology Program Faculty (39)
  5. Sloan Kettering Institute Postdocs (37)
  6. Hematologic Malignancies, Division of (29)
  7. Center for Hematologic Malignancies (27)
  8. Solid Tumor Oncology Division (24)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  10. Melanoma and Immunotherapeutics Service (19)
  1. "cd4-positive t-lymphocytes"
Formats
  1. Journal Article (164)
  2. Guidelines (1)
Groups
  1. Department of Medicine (56)
  2. Sloan Kettering Institute Faculty (56)
  3. GSK Faculty (53)
  4. Immunology Program Faculty (39)
  5. Sloan Kettering Institute Postdocs (37)
  6. Hematologic Malignancies, Division of (29)

More Groups

People
  1. Lloyd Old (28)
  2. Gerd Ritter (18)
  3. Alan Houghton (16)
  4. Jedd Wolchok (15)
  5. Sacha Gnjatic (14)
  6. James Allison (12)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (4)
  5. 2017 (1)
  6. 2014 (1)

More Years

Publications
  1. Journal of Immunology (23)
  2. Journal of Experimental Medicine (12)
  3. Blood (11)
  4. Clinical Cancer Research (11)
  5. Proceedings of the National Academy of Sciences of the United States of America (8)
  6. Journal of Clinical Investigation (7)

More Publications

Publishers
  1. The American Association of Immunologists, Inc (23)
  2. American Association for Cancer Research (15)
  3. Nature Publishing Group (12)
  4. Rockefeller University Press (12)
  5. American Society of Hematology (11)
  6. Elsevier Inc. (10)

More Publishers

Results (165)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients with Epstein Barr virus-positive lymphomas have decreased CD4 + T-cell responses to the viral nuclear antigen 1
    Journal Article

    Heller, K. N.; Arrey, F.; Steinherz, P.; Portlock, C.; Chadburn, A.; Kelly, K.; Münz, C.
    International Journal of Cancer (2008)

    Fulltext@MSK | Save
  • Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection
    Journal Article

    Gallegos, A. M.; Pamer, E. G.; Glickman, M. S.
    Journal of Experimental Medicine (2008)

    Fulltext@MSK | Save
  • Peptide vaccines for myeloid leukaemias
    Journal Article

    Dao, T.; Scheinberg, D. A.
    Best Practice and Research: Clinical Haematology (2008)

    Fulltext@MSK | Save
  • Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo
    Journal Article

    Casado, J. G.; Janda, J.; Wei, J.; Chapatte, L.; Colombetti, S.; Alves, P.; Ritter, G.; Ayyoub, M.; Valmori, D.; Chen, W.; more...
    European Journal of Immunology (2008)

    Fulltext@MSK | Save
  • Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: A multicenter trial of the AIDS malignancy consortium
    Journal Article

    Brinker, B. T.; Krown, S. E.; Lee, J. Y.; Cesarman, E.; Chadburn, A.; Kaplan, L. D.; Henry, D. H.; Von Roenn, J. H.
    Cancer (2008)

    Fulltext@MSK | Save
  • Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
    Journal Article

    Atanackovic, D.; Altorki, N. K.; Cao, Y.; Ritter, E.; Ferrara, C. A.; Ritter, G.; Hoffman, E. W.; Bokemeyer, C.; Old, L. J.; Gnjatic, S.
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save
  • Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4 + and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells
    Journal Article

    May, R. J.; Dao, T.; Pinilla-Ibarz, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Maslak, P.; Scheinberg, D. A.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas
    Journal Article

    Malhotra, S.; Kim, T.; Zager, J.; Bennett, J.; Ebright, M.; D'Angelica, M.; Fong, Y.
    Surgery (2007)

    Fulltext@MSK | Save
  • Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection
    Journal Article

    Loke, P.; Gallagher, I.; Nair, M. G.; Zang, X.; Brombacher, F.; Mohrs, M.; Allison, J. P.; Allen, J. E.
    Journal of Immunology (2007)

    Fulltext@MSK | Save
  • Changes in the levels of CD4(+) and CD8(+) T-lymphocytes after strontium-89 chloride therapy for painful bone metastases in patients correlate with treatment efficacy
    Journal Article

    Li, Y.; Li, X. F.; Ma, Y.; Fang, N.; Russell, J.; Ma, D.; Sun, X.; Han, X.; Yang, H.; Kinuya, S.
    Cancer Biotherapy and Radiopharmaceuticals (2007)

    Fulltext@MSK | Save